Trial Profile
An Investigator-Initiated, Open-lable, Pilot Study to Evaluate the Efficacy and Safety of Apremilast for the Treatment of Moderate to Severe Inflammatory Rosacea.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Nov 2015
Price :
$35
*
At a glance
- Drugs Apremilast (Primary)
- Indications Rosacea
- Focus Therapeutic Use
- 25 Nov 2015 New trial record